Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Study report: Primary cutaneous lymphomas

Skin-directed or systemic therapy?

    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • RX
    • Studies
  • 2 minute read

Diffuse large B-cell lymphoma is the most common malignant tumor of the lymphatic system. The primary objective of a retrospective clinical study led by Charité-Universitätsmedizin Berlin was to compare systemic and skin-directed therapies in primary cutaneous lymphoma (CBCL) with regard to survival and recurrence rates as well as time to the next line of therapy.

There are few research findings to date regarding the effectiveness of systemic and skin-directed therapies (SDT) in primary cutaneous B-cell lymphoma (CBCL), as well as the respective survival and recurrence rates. The “time to next treatment” (ZZNT) is defined as the time from the start of treatment to the start of the next line of therapy and serves as a surrogate marker for efficacy, toxicity and patient compliance when evaluating treatment options. To date, ZZNT has been evaluated in clinical trials primarily for primary cutaneous T-cell lymphomas.

Methodology

Clinical data from patients of the Central Registry for Cutaneous Lymphoma of the Charité were extracted and analyzed using descriptive statistics. A total of 98 patients with CBCL were identified: 44 with follicular center lymphoma (FCL), 43 with marginal zone lymphoma (MZL) and 11 with diffuse large B-cell lymphoma/leg type (DLBCL-LT). The average age at first diagnosis was 53, 48 and 76 years respectively. The SDT evaluated in this study included excision, radiotherapy, triamcinolone intralesional (i.l.) and topical steroids; systemic therapies included interferon-α (IFN-α), (R)-CHOP chemotherapy and rituximab.

Results

On average, patients received 2 treatments. In patients with FCL, triamcinolone (i.l.), radiotherapy and excision were associated with the longest CNT, averaging 29, 24 and 24 months, respectively (Table 1) . In MCL, excision, IFN-α and radiotherapy were associated with the longest CNT, averaging 23, 15 and 13 months, respectively. In DLBCL-LT, CHOP, excision and rituximab had the largest ZZNT with an average of 38, 32 and 18 months, respectively. Within 5 years of initial diagnosis, 36% and 35% of patients with FCL and MZL respectively relapsed. In patients with DLBCL-LT, the survival rate 5 years after initial diagnosis was 27%.

Conclusion

This retrospective study represents the first investigation of ZZNT in patients with CBCL. In this cohort, FCL and MZL patients relapsed with similar frequency. Aggressive courses of DLBCL-LT have been confirmed in the literature. Compared to systemic therapies, SDT showed superiority in FCL and MZL by an average of 4-16 months. In view of the rarity of CBCL and the nevertheless high number of cases in the present cohort, the results can support clinical treatment decisions.

Source: Cankaya R, et al.: Hautgerichtete oder systemische Therapien bei primär kutanem B-Zell-Lymphom? Eine retrospektive Analyse der Zeit bis zur nächsten Therapieline, ePoster (eP016), Deutscher Hautkrebskongress/ ADO-Jahrestagung, Hamburg, 06–09.09.2023.

DERMATOLOGIE PRAXIS 2023; 33(6): 25
InFo ONKOLOGIE & HÄMATOLOGIE 2023: 11(6): 31

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • B-cell lymphomas
  • Diffuse large B-cell lymphoma
  • Primary cutaneous lymphomas
  • skin-directed therapy
  • Systemic therapy
Previous Article
  • Translational neuroscience

Treatment research in psychiatry, neurology and psychology

  • Congress Reports
  • Neurology
  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
Next Article
  • Tofacitinib for ulcerative colitis

Study shows real-world evidence for efficacy and safety

  • Congress Reports
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Type 2 diabetes

Pharmacotherapy can lead to remission

    • Education
    • Endocrinology and Diabetology
    • Nutrition
    • Pharmacology and toxicology
    • RX
View Post
  • 4 min
  • Case Report

Mycosis fungoides in an 11-year-old child

    • Allergology and clinical immunology
    • Cases
    • Dermatology and venereology
    • Education
    • Oncology
    • Pediatrics
    • RX
    • Studies
View Post
  • 6 min
  • EHA 2025

Progress in multiple myeloma

    • Congress Reports
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 6 min
  • Interstitial lung diseases

Artificial intelligence improves ILD diagnosis

    • Education
    • General Internal Medicine
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 7 min
  • Management of patients after alloHCST

ERS/EBMT guideline recommendations on pulmonary cGvHD

    • Education
    • General Internal Medicine
    • Genetics
    • Hematology
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • From early intervention to individualization

The new guidelines at a glance

    • Cardiology
    • Congress Reports
    • RX
    • Studies
View Post
  • 3 min
  • Pyoderma gangraenosum

New study data confirm the validity of the PARACELSUS score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Orthopedics
    • Prevention and health care
    • RX
    • Studies
    • Surgery
View Post
  • 8 min
  • Progressive multiple sclerosis

New horizons: from BTK inhibitors to remyelination

    • Education
    • Genetics
    • Neurology
    • RX
    • Studies
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Colorectal cancer screening – an update
  • 2
    Yellow nail and Swyer-James syndrome
  • 3
    Individual therapy management for an optimized outcome – an update
  • 4
    Doing sport without fear or risk
  • 5
    UV protection and skin cancer screening – Update 2025

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.